Advanced Cancer Protocols

 Optimizing the Cancer Control, Repair & Reversal Code: a precondition to Optimal Longevity

« …si j’avais un cancer, je n’irai jamais dans un centre anticancéreux classique. Seules les victimes du cancer qui vivent loin de ces centres ont une chance. » “If i had a cancer, i would never to to a conventional anti cancer center. Only cancer victims who live far from these centers have a chance”. (Source) Pr Georges Mathé (famous contemporary French oncologist

For the ACR Institute, there is no question that integrative oncology’s modalities and clinics are much better than conventional oncology clinics. The well known Professor Georges Mathé (oncologist) used to say: “Si j’avais une tumeur, je n’irais pas dans un centre anticancéreux » (Le Monde, 4 mai 1998) (“If i had a tumor, i would not go to an anticancer center”) (Source). Among a few other French oncologists who have questioned the very legitimacy of conventional oncology’s thinking and modalities, I’m invoking Georges Mathé because he was recognized in the US as a cancer, stem cell and bone transplant pioneer in that he proved as early as 1963 that cancer was curable via the immune system. He also demonstrated that stem cells could both heal radiation damage and fight cancer. Dr. Joseph H. Antin, chief of stem cell transplantation at the famous Dana-Farber Cancer Institute in Boston, summed up Mathé’s work: “It was quite a leap of scientific genius. He’s one of the original innovators. Much of what we have accomplished can be linked back in a fairly direct way to the work that he did in the 1950s and ’60s.” (“Dr. Georges Mathé, Transplant Pioneer, Dies at 88”New York Times, Source).

Notwithstanding their nuisance, cancer cells have mastered the art of longevity since their “innate evolutionarily-based intelligence” has tweaked its genome to produce a continuous fresh supply of telomerase enzymes thanks to which they can divide endlessly and remain forever “strong” and “young”. In this Presentation, we will unmask cancer’s intrinsic weaknesses and explain a few of its underlying mechanisms. But between cancer as a biological reality and conventional oncology as a system of deleterious dogmas, the central problem lies with Conventional Oncology.We will thus discuss the limits of conventional oncology in relation to the strengths of holistic cancer  protocols.

From 1991 to the 2018, published studies, including in the Lancet Journal, have proven beyond any reasonable doubt that systemic cytotoxic chemo-blasting more often than not doesn’t durably save lives of those who have “solid” cancers. The five year survival rates for liquid canccers (e.g. lymphomas and, inter alia, leukemias) are much better, but these malignancies often come back with a vengeance after the five-year period and-or have toxic effects that seriously affect the patient’s ability to reach a healthy 120 years of lifespan. Worse, the evidence shows that with conventional chemotherapy, cancer patients’ demise tends to be accelerated. While radiation and cytotoxic chemo do shrink tumors, there are no published studies the H.M. Institute is aware of that show a positive correlation between tumor shrinkage and significant long-term survivability. Thus, the emerging reality (for the last 40 to 50 years) is that most of these conventional medical interventions will weaken what can restore the patient’s “élan vital” (i.e., a notion from Prof. Henri Bergson which include the immune, digestive, microbiota, endocannabinoid and neurological systems) while fueling what metastasizes cancer, in particular, the microscopic circulating tumor and stem cells that most conventional oncologists still refuse to inform the patient about, in violation of medmal law and ethics. Even most of conventional oncology’s more recent targeted monoclonal antibodies, signaling inhibitors, genetic interventions and immunotherapeutics have toxic side effects that can be avoided with alternative and holistic oncology. Many of these targeted therapies including immunotherapeutics have been hyped misleadingly as new cancer “cure-alls”. While it is true that a small percentage of cancers go away with immunotherapeutics, these effects are usually not long lasting, autoimmunity can be triggered, the modalities are very expensive and the outcome of holistic oncology’s cases tend to be much better, provided the patient is compliant with a holistic lifestyle and restorative protocols.

Leave a Reply